References 579 & 438. Liu R, Jiang G, Gao P, Li G, Nie L, Yan J, et al. Non-invasive Amide Proton Transfer Imaging and ZOOM DiffusionWeighted Imaging in Differentiating Benign and Malignant Thyroid Micronodules. Front Endocrinol. 2018;9:747. https://doi.org/10.3389/fendo.2018.00747. 439. Wang H, Wei R, Liu W, Chen Y, Song B. Diagnostic efficacy of multiple MRI parameters in differentiating benign vs. malignant thyroid nodules. BMC Med Imaging. 2018;18:50. https://doi.org/10.1186/s12880-018-0294-0. 440. Song M, Yue Y, Guo J, Zuo L, Peng H, Chan Q, et al. Quantitative analyses of the correlation between dynamic contrast-enhanced MRI and intravoxel incoherent motion DWI in thyroid nodules. Am J Transl Res. 2020;12:39843992. 441. Wang H, Song B, Ye N, Ren J, Sun X, Dai Z, et al. Machine learning-based multiparametric MRI radiomics for predicting the aggressiveness of papillary thyroid carcinoma. Eur J Radiol. 2020;122:108755. https://doi.org/10.1016/j. ejrad.2019.108755. 442. Wei R, Wang H, Wang L, Hu W, Sun X, Dai Z, et al. Radiomics based on multiparametric MRI for extrathyroidal extension feature prediction in papillary thyroid cancer. BMC Med Imaging. 2021;21:20. https://doi.org/10.1186/ s12880-021-00553-z. 443. Saggiorato E, Angusti T, Rosas R, Martinese M, Finessi M, Arecco F, et al. <sup>99m</sup>Tc-MIBI Imaging in the Presurgical Characterization of Thyroid Follicular Neoplasms: Relationship to Multidrug Resistance Protein Expression. 2009;50:1785-1793. https://doi.org/10.2967/jnumed.109.064980. 444. Piccardo A, Puntoni M, Treglia G, Foppiani L, Bertagna F, Paparo F, et al. Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology. Eur J Endocrinol. 2016;174:693-703. https://doi.org/10.1530/eje-15-1199. 445. Armefti S, Mettler J, Schmidt M, Faust M, Engels M, Schultheis AM, et al. Could Negative Tc-99mMethoxyisobutylisonitrile (MIBI) Scintigraphy Obviate the Need for Surgery for Bethesda III and IV Thyroid Nodules? 2021;2:260-267. 446. Campenni A, Siracusa M, Ruggeri RM, Laudicella R, Pignata SA, Baldari S, et al. Differentiating malignant from benign thyroid nodules with indeterminate cytology by (99m)Tc-MIBI scan: a new quantitative method for improving diagnostic accuracy. Sci Rep. 2017;7:6147. https://doi.org/10.1038/s41598-017-06603-3. 447. Schenke SA, Campennì A, Tuncel M, Bottoni G, Sager S, Bogovic Crncic T, et al. Diagnostic Performance of (99m)TcMethoxy-Isobuty-Isonitrile (MIBI) for Risk Stratification of Hypofunctioning Thyroid Nodules: A European Multicenter Study. Diagnostics (Basel, Switzerland). 2022;12. https://doi.org/10.3390/diagnostics12061358. 448. Heinzel A, Müller D, Behrendt FF, Giovanella L, Mottaghy FM, Verburg FA. Thyroid nodules with indeterminate cytology: molecular imaging with ⁹⁹mTc-methoxyisobutylisonitrile (MIBI) is more cost-effective than the Afirma gene expression classifier. Eur J Nucl Med Mol Imaging. 2014;41:1497-1500. https://doi.org/10.1007/s00259-014-2760-4. 449. Hindié E, Ugur O, Fuster D, O’Doherty M, Grassetto G, Ureña P, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009;36:1201-1216. https://doi.org/10.1007/s00259-009-1131-z. 450. Bertagna F, Treglia G, Piccardo A, Giubbini R. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. The Journal of clinical endocrinology and metabolism. 2012;97:3866-3875. https://doi.org/10.1210/ jc.2012-2390. 451. de Leijer JF, Metman MJH, van der Hoorn A, Brouwers AH, Kruijff S, van Hemel BM, et al. Focal Thyroid Incidentalomas on (18)F-FDG PET/CT: A Systematic Review and Meta-Analysis on Prevalence, Risk of Malignancy and Inconclusive Fine Needle Aspiration. Frontiers in endocrinology. 2021;12:723394. https://doi.org/10.3389/fendo.2021.723394. 452. Muñoz Pérez N, Villar del Moral JM, Muros Fuentes MA, López de la Torre M, Arcelus Martínez JI, Becerra Massare P, et al. Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm? Langenbeck’s Archives of Surgery. 2013;398:709-716. https://doi.org/10.1007/s00423-013-1070-9. 453. Kresnik E, Gallowitsch HJ, Mikosch P, Stettner H, Igerc I, Gomez I, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery. 2003;133:294-299. https://doi.org/https://doi.org/10.1067/msy.2003.71. 454. de Koster EJ, de Geus-Oei LF, Brouwers AH, van Dam E, Dijkhorst-Oei LT, van Engen-van Grunsven ACH, et al. [(18)F]FDG-PET/ CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial. Eur J Nucl Med Mol Imaging. 2022. https://doi.org/10.1007/s00259-021-05627-2. 455. de Koster EJ, Noortman WA, Mostert JM, Booij J, Brouwer CB, de Keizer B, et al. Quantitative classification and radiomics of [(18)F]FDG-PET/CT in indeterminate thyroid nodules. Eur J Nucl Med Mol Imaging. 2022;49:2174-2188. https://doi.org/10.1007/s00259-022-05712-0. 456. Rosario PW, Rocha TG, Calsolari MR. Fluorine-18-fluorodeoxyglucose positron emission tomography in thyroid nodules with indeterminate cytology: a prospective study. Nucl Med Commun. 2019;40:185-187. https://doi. org/10.1097/mnm.0000000000000946. 457. Pathak KA, Goertzen AL, Nason RW, Klonisch T, Leslie WD. A prospective cohort study to assess the role of FDGPET in differentiating benign and malignant follicular neoplasms. Annals of Medicine and Surgery. 2016;12:27-31. https://doi.org/https://doi.org/10.1016/j.amsu.2016.10.008.
RkJQdWJsaXNoZXIy MTk4NDMw